# Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study

> **NCT06647901** · PHASE1,PHASE2 · RECRUITING · sponsor: **Tang Xiaodong** · enrollment: 45 (estimated)

## Conditions studied

- Giant Cell Tumor of Bone

## Interventions

- **DRUG:** ICG (Indocyanine Green)

## Key facts

- **NCT ID:** NCT06647901
- **Lead sponsor:** Tang Xiaodong
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-23
- **Primary completion:** 2026-08-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2024-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06647901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06647901, "Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06647901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*